ADAP
Adaptimmune Therapeutics
ADAP
ADAP
80 hedge funds and large institutions have $256M invested in Adaptimmune Therapeutics in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 14 closing their positions.
Holders
80
Holders Change
+2
Holders Change %
+2.56%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
16
Increased
17
Reduced
23
Closed
14
Calls
$379K
Puts
$124K
Net Calls
+$255K
Net Calls Change
+$255K